Details of the Drug
General Information of Drug (ID: DMOZAM6)
Drug Name |
1-(4-Aminobenzyl)-1H-imidazole
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
56643-85-7; 4-Imidazol-1-ylmethylphenylamine; 4-(1H-imidazol-1-ylmethyl)aniline; 4-((1H-imidazol-1-yl)methyl)aniline; 4-(imidazol-1-ylmethyl)aniline; 4-[(1-Imidazolyl)methyl]aniline; 4-Imidazol-1-ylmethyl-phenylamine; 4-[(1H-Imidazol-1-yl)methyl]aniline; 1-(4-Aminobenzyl)imidazole; CHEMBL598389; 4-(imidazolylmethyl)phenylamine; Benzenamine, 4-(1H-imidazol-1-ylmethyl)-; 1-(4-Aminobenzyl)-1H-imidazole; BAS 06504682; AC1LOLP2; SCHEMBL77025; AC1Q520P; CTK5A5496; DTXSID40361425; 4-(imidazol-1-yl)methyl-aniline
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 173.21 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.9 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||